ID Pharma Co Ltd - Company Review
ID Pharma Co Ltd - Company ReviewSummary
ID Pharma Co Ltd (ID Pharma), formerly DNAVEC Corp is a manufacturer and commercializer of gene medicines. The company develops regenerative medicines, cell therapy, and other bio products. It offers vector platforms such as Sendai virus vector in its drug development process. ID Pharma’s vector technology is used to develop drugs in the bio-business classes such as gene therapy, gene vaccine, antibody, protein production and gene function analysis. The company develops gene therapies for cardiovascular, respiratory, autoimmune, ophthalmologic diseases, and cancer. Its gene vaccines are used for the treatment of tuberculosis, influenza, malaria, Alzheimer's disease, tumor, and Parkinson's disease. The company has operations in the US, Japan and China. ID Pharma is headquartered in Tsukuba, Japan.
This comprehensive company report of ID Pharma Co Ltd provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.